Amgen gets FDA approval for small-cell lung-cancer treatment
Amgen on Thursday received approval from U.S. regulators for its drug to treat a form of late-stage lung-cancer.
Amgen on Thursday received approval from U.S. regulators for its drug to treat a form of late-stage lung-cancer.